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Abstract
Background: Dietary intakes of red meat and fat are established risk factors for both colorectal cancer (CRC) and
cardiovascular disease (CVDs). Recent studies have shown a mechanistic link between TMAO, an intestinal microbial
metabolite of red meat and fat, and risk of CVDs. Data linking TMAO directly to CRC is, however, lacking. Here, we
present an unbiased data-driven network-based systems approach to uncover a potential genetic relationship
between TMAO and CRC.
Materials and methods: We constructed two different epigenetic interaction networks (EINs) using chemical-gene,
disease-gene and protein-protein interaction data from multiple large-scale data resources. We developed a
network-based ranking algorithm to ascertain TMAO-related diseases from EINs. We systematically analyzed disease
categories among TMAO-related diseases at different ranking cutoffs. We then determined which genetic pathways
were associated with both TMAO and CRC.
Results: We show that CVDs and their major risk factors were ranked highly among TMAO-related diseases,
confirming the newly discovered mechanistic link between CVDs and TMAO, and thus validating our algorithms.
CRC was ranked highly among TMAO-related disease retrieved from both EINs (top 0.02%, #1 out of 4,372 diseases
retrieved based on Mendelian genetics and top 10.9% among 882 diseases based on genome-wide association
genetics), providing strong supporting evidence for our hypothesis that TMAO is genetically related to CRC. We
have also identified putative genetic pathways that may link TMAO to CRC, which warrants further investigation.
Through systematic disease enrichment analysis, we also demonstrated that TMAO is related to metabolic
syndromes and cancers in general.
Conclusions: Our genome-wide analysis demonstrates that systems approaches to studying the epigenetic
interactions among diet, microbiome metabolisms, and disease genetics hold promise for understanding disease
pathogenesis. Our results show that TMAO is genetically associated with CRC. This study suggests that TMAO may
be an important intermediate marker linking dietary meat and fat and gut microbiota metabolism to risk of CRC,
underscoring opportunities for the development of new gut microbiome-dependent diagnostic tests and
therapeutics for CRC.
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Introduction
Colorectal cancer (CRC) represents the second most
common cause of cancer in women (9.2%) and the third
most common in men (10.0%). Diet clearly plays an
important role in colon carcinogenesis. The Western
diet, characterized by high fat and meat consumption,
has been associated with increased risk of colorectal
cancer in a large number of epidemiological studies
[1-3]. The risk association is particularly strong for red
meat intake. In effect, an extensive review of the existing
evidence by an international panel of experts concluded
that a high intake of red meat is a convincing and prob-
able cause of colorectal cancer [4].
The complex gut microbiota harbored by individuals
have long been proposed to play an important role in
colon carcinogenesis [5-7]. Recent studies comparing
patients with colorectal neoplasia and healthy controls
have found differences either in the relative abundance of
certain microbial species or in the taxonomic composition
of the microbiome. In particular, three studies using high
throughput sequencing to characterize the composition of
microbiota have discovered enrichment of Fusobacterium
species in human colorectal tumors or adenomas as com-
pared to matched normal control tissues, providing direct
evidence for a link of gut microbiome to colorectal cancer
[8-10]. The exact mechanisms by which gut microflora
may modulate colorectal cancer risk, however, remain
largely unexplored.
Recent studies have discovered that trimethylamine
N-oxide (TMAO) generated by gut microbiota metabo-
lism of dietary L-carnitine, a trimethylamine abundant
in red meat, and dietary phosphatidylcholine is mechan-
istically linked to risk of cardiovascular diseases (CVDs)
[11-14]. It is further shown that human gut microbiota
are required to form TMAO from dietary red meat and
fat, and specific bacterial taxa are associated with both
plasma levels of TMAO and dietary meat and fat
intakes. These studies suggest a novel mechanism invol-
ving a complex interplay of human gut microbial com-
munity and diet for the observed relationship between
dietary red meat and fat consumption and cardiovascu-
lar disease.
Whether TMAO plays a similar role in colon carcino-
genesis has not been explored. Given the striking similarity
of colorectal cancer and cardiovascular diseases in risk
association with dietary red meat/fat intakes, we hypothe-
size that TMAO is an intermediate marker linking dietary
red meat and fat and gut microbial metabolism to colorec-
tal cancer. Here, we represent a genome-wide systems
approach to the discovery of the genetic links between
CRC and TMAO by reasoning over vast amounts of
disease-gene association, protein-protein interaction and
chemical-gene association data from multiple databases
using advanced network-based ranking algorithms.
Materials and methods
The experimental framework consists of the following
steps: (1) we constructed two different genetic disease net-
works (GDNs) using disease-gene and protein-protein
interaction data from multiple large-scale data resources;
(2) we modeled the epigenetic interactions between
TMAO and diseases by transforming GDNs into epige-
netic interaction networks (EINs); (3) we developed a net-
work-based ranking algorithm to find TMAO-related
diseases from GDNs. These diseases share a high degree
of genetic similarities with TMAO; (4) we validated recent
findings that TMAO is associated with cardiovascular dis-
eases; (5) we tested our hypothesis that TMAO might be
genetically linked to CRC; (6) we systematically analyzed
disease categories among TMAO-related diseases at differ-
ent ranking cutoffs; and (7) we determined which genetic
pathways were associated with both TMAO and CRC.
Construct genetic disease networks (GDNs)
Construct GDN based on OMIM genetics (GDN_OMIM)
We constructed two separate GDNs using disease-gene
association data from two complementary data resources.
The first one is the Online Mendelian Inheritance in
Man (OMIM), a comprehensive database of human
genes and genetic phenotypes mainly for rare Mendelian
genetic disorders [15]. We downloaded the OMIM data-
base and mapped gene names to their corresponding
approved human gene symbols as defined by the HUGO
Gene Nomenclature Committee (HGNC) [16]. We
extracted a total of 15,462 disease-gene pairs from the
OMIM database, representing 5,983 diseases and 8,831
genes. On GDN_OMIM, two diseases were connected if
their associated genes (proteins) interact. The edge
weights were determined by the numbers of protein-
protein interaction (PPI) pairs between two diseases (Di







Gik is a gene associated with Di, Gj l is a gene associated
with Dj , and Gik is the same as or interacts with Gj l
according to known protein-protein (PPI) association
data. The PPI data was obtained from the STRING data-
base, a database of known and predicted protein interac-
tions [17]. Currently, STRING contains 5,214,234
proteins from 1,133 organisms. From the STRING data-
base, we obtained a total of 4,137,054 human PPI pairs
representing 17,756 human proteins.
Construct GDN based on GWAS genetics (GDN_GWAS)
The second source of disease genetics we utilized in con-
structing GDNs was the Catalog of Published Genome-
Wide Association Studies from the US National Human
Genome Research Institute (NHGRI), an exhaustive source
containing the description of diseaseand trait-associated sin-
gle nucleotide polymorphisms (SNPs) from published
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GWAS data [18]. Different from diseases in the OMIM
database, diseases in the GWAS catalog are mainly common
complex diseases. We first mapped SNPs to their associated
strongest genes, which were subsequently mapped to their
corresponding approved human gene symbols as defined by
the HGNC. In total, we obtained 22,470 disease/trait-gene
pairs, representing 881 diseases/traits and 8,689 genes. On
GDN_GWAS, two diseases were connected if their asso-
ciated genes (proteins) interact and the edge weights were
the numbers of PPI pairs between two diseases as described
above. In summary, the disease network GDN_OMIM
consisted of 4,848 nodes and 882,751 edges; GDN_GWAS
consisted of 882 nodes and 200,758 edges. Compared to
GDN_GWAS, GDN_OMIM contained significantly more
diseases, but fewer edges between any two nodes.
Model the epigenetic interactions between TMAO and
diseases by transforming disease networks into
epigenetic interaction networks (EINs)
We modeled the epigenetic interactions between TMAO
and diseases on both GDN_OMIM and GDN_GWAS by
inserting TMAO into these two disease networks. We
obtained human genes associated with TMAO from
STITCH, a publicly available database of known and
predicted interactions of chemicals and proteins [19].
Currently, STITCH contains interactions for between
300,000 small molecules and 2.6 million proteins from
1,133 organisms, with each interaction associated with a
score measuring the evidence of the association. In
STITCH, TMAO is associated with a total of 553 genes
from 932 species, including 54 genes from humans.
Table 1 shows ten human genes associated with TMAO.
We first inserted a pseudo-node representing TMAO
into GDNs. This node was then connected to disease
nodes on GDNs if TMAO-associated genes interact with
disease-associated genes. The edge weights were deter-
mined by the numbers of interacting genes between the
newly inserted node (T) and existing disease nodes (Dj)






Gjl where GT k is a
gene associated with TMAO, Gj l is a gene associated with
Dj , and GT k is the same as or interacts with Gj l. The
intuition is that: if TMAO-associated genes participate in
the same pathways as disease-associated genes, we can
hypothesize that TMAO may be involved in disease patho-
genesis. The degree of relatedness between TMAO and
diseases was determined by the numbers of interacting
gene pairs. After inserting the node “TMAO”, we re-nor-
malized the matrices represented by EINs and applied an
existing network-based ranking algorithm to find diseases
that share high genetic similarities with TMAO (Figure 1).
The network-based ranking algorithm was used to find
diseases that are related to TMAO both directly and indir-
ectly by taking into account of inter-relationships among
diseases. After this step, we created two EINs: the EIN_O-
MIM was created based on GDN_OMIM and the EIN_G-
WAS was created based on GDN_GWAS.
Develop network-based ranking algorithm to find
diseases that share high genetic similarities with TMAO
We then developed a network-based ranking algorithm to
prioritize diseases on EINs based on their genetic com-
monalities with TMAO. We retargeted the TopicSensitive
PageRank (TSPR) algorithm to rank similar diseases for a
given input (TMAO in our study). TSPR is a context-sen-
sitive ranking algorithm for web searches developed by
Taher Haveliwala [20]. Versions of this approach have
been used in prioritizing disease genes using networks
consisting of same node types (i.e. diseases or genes)
[21,22]. In this study, we applied the same algorithm to a
heterogeneous network consisting of disease nodes and
chemical nodes (TMAO in this study) in order to find
TMAO-related diseases. The iterative networkbased rank-
ing algorithm in finding similar diseases to a given input is
defined as: pt+1 = (1 − r)M pt + rp0, wherein M is the col-
umn-normalized adjacency matrix of EINs, g is a preset
probability of restarting from the initial seed node (g = 0.1
in this study), and pt is a vector in which the ith element
holds the normalized ranking score of disease i at tth itera-
tion. The initial probability vector p0 contains normalized
probability for input. In our study, p0 contains TMAO,
with a probability of 1.0. Diseases are then ranked accord-
ing to the value in the steady-state probability vector,
which is obtained by iterating the algorithm until the
change between pt+1 and pt is less than 106.
Validate recent findings that TMAO is associated with
cardiovascular diseases
Recent studies indicate that high levels of TMAO in the
blood are associated with an increased risk of cardiovas-
cular diseases [11-14]. We examined the rankings of
Table 1. Ten TMAO-associated human genes
Gene Symbol Gene name
MBD2 Methyl-CpG binding domain protein 2
FMO3 Flavin containing monooxygenase 3
RORC RAR-related orphan receptor C
SGCG Sarcoglycan, gamma (35kDa dystrophin-associated
glycoprotein)
PNKD Paroxysmal nonkinesigenic dyskinesia
RNASE1 Ribonuclease, RNase A family, 1 (pancreatic)
NKRF NFKB repressing factor
PFKM Phosphofructokinase, muscle
MOCS1 Molybdenum cofactor synthesis 1
TRA2A Transformer 2 alpha homolog
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cardiovascular diseases and their major risk factors,
including high blood cholesterol and triglyceride, high
blood pressure, diabetes, and obesity, among diseases
retrieved from EINs using TMAO as seed. As positive
controls, these diseases are expected to rank highly
among TMAO-related diseases.
Test our hypothesis that TMAO may be genetically
associated with CRC
In order to provide evidence supporting our hypothesis
that TMAO may be involved in CRC pathogenesis, we
tested whether CRC would rank highly among TMAOre-
lated diseases retrieved from both EINs. High rankings of
CRC would imply that TMAO and CRC share high genet-
ics and that TMAO might be associated with CRC
carcinogenesis.
Analyze diseases enriched among top-ranked TMAO-
related diseases
To better understand TMAO-related diseases, we deter-
mined the kinds of diseases that were enriched among
top-ranked diseases retrieved from EINs. We classified dis-
eases into different categories using the 10th revision of
the International Statistical Classification of Diseases and
Related Health Problems (ICD10), a disease classification
scheme designated by the World Health Organization
(WHO) [23]. The ICD10 includes 22 highest-level disease
classes. We used 16 of the 22 chapters and excluded six
non-specific disease classes. Since the terms used in
ICD10 may be different from those used in EINs, we
mapped disease terms in ICD10 to their synonyms
through the unified medical language system (UMLS)
unique concept identifiers [24]. Disease chapters and the
numbers of diseases in each chapter are listed in Table 2.
Since EIN_OMIM contains 4,848 disease nodes and
EIN_GWAS contains 882 nodes, we performed disease
class enrichment analysis on TMAO-related diseases
retrieved from EIN_OIMIM only. For diseases ranked at
10 different ranking cutoffs (top 10%, 20%, . . . 100%), we
calculated percentages of the sixteen ICD10 disease
classes among them.
Identify genetic pathways linking TMAO to CRC
In order to gain insights into common mechanistic rela-
tionships shared between TMAO and CRC, we identified
and ranked genetic pathways linking them (Figure 2).
Functions of highly enriched pathways might provide
insights into common molecular mechanisms linking
TMAO to CRC. TMAO is associated with 54 human
genes based on the STITCH database. CRC is associated
with 65 genes according to the GWAS catalog and 53
genes according to the OMIM database. There is no
direct overlap between CRC-associated genes from
OMIM and those from the GWAS catalog. In addition,
there is no overlap between TMAO-associated genes and
CRC-associated genes. We analyzed gene-associated
pathways using the pathway data (a total of 10,295 path-
ways and gene sets) from the Molecular Signatures Data-
base (MSigDB), a collection of annotated genetic
pathways or gene sets from multiple sources [25]. We
ranked these pathways based on the numbers of genes




Gi is a TMAOor CRC-associated gene that a given
pathway contains. We then identified pathways that
contain both TMAOand CRC-associated genes and
ranked them base on the number of interacting gene-







Gj where Gi is a TMAO-
associated gene and Gj is a CRC-associated gene.
Results
Cardiovascular diseases (CVDs) are genetically related to
TMAO
Recent studies indicate that high levels of TMAO in the
blood are associated with an increased risk of CVDs. Our
results demonstrated that CVDs as well as their major
risk factors, including high blood cholesterol and trigly-
ceride, high blood pressure, diabetes, and obesity, were
ranked highly among TMAO-related diseases retrieved
from both EIN_OMIM and EIN_GWAS. We retrieved a
Figure 1 Finding TMAO-related diseases. Transforming GDNs into epigenetic interaction network (EINs) and finding TMAO-related diseases
from transformed EINs.
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total of 878 diseases/traits from EIN_GWAS, among
which obesity-related traits was ranked at top 1 (top
0.11%) and coronary heart disease at top 7 (top 0.80%).
Other CVDrelated risk factors, including HDL cholesterol
(top 1.13%), type 2 diabetes (top 1.48%), LDL cholesterol
(top 1.82%), and metabolic syndrome (top 3.64%) were
also ranked highly (Table 3).
We retrieved a total of 4,732 diseases from EIN_OMIM
using TMAO as input. Similar to results based on
EIN_OMIM, CVDs and their major risk factors, includ-
ing myocardial infarction (top 0.23%), ventricular tachy-
cardia (0.25%), diabetes mellitus, noninsulin-dependent
(top 0.32%), and coronary artery disease, susceptibility to
(top 0.51%), were ranked highly. Even though the dis-
eases from EIN_GWAS (mainly common complex dis-
eases) and from EIN_OMIM (mainly rare Mendelian
disorders) are largely complementary, the high rankings
of CVDs and their major risk factors among TMAO-
related diseases retrieved from both networks confirmed
recent studies and validated our network-based approach
in finding TMAO-related diseases.
Colorectal cancer is highly related to TMAO
Table 4 shows top ten TMAO-related diseases/traits
retrieved from EIN_GWAS and from EIN_OMIM. Color-
ectal cancer was ranked at top 1 (top 0.02%) among 4732
diseases retrieved from EIN_OMIM and at top 10.6%
among the 882 retrieved diseases/traits. The high rankings
of colorectal cancers based on both networks provided
strong evidence supporting our hypothesis that TMAO
may be involved in colorectal cancer pathogenesis. Since
the GWAS catalog mainly contains common complex dis-
eases/traits and the OMIM database mainly contains Men-
delian diseases, the top-ranked diseases retrieved from the
two disease networks are quite different. The top ten
TMAO-related diseases/traits from EIN_GWAS included
several CVD-related risk factors, including obesity-related
traits, metabolite levels, coronary heart disease, metabolic
traits, and HDL cholesterol. Interestingly, three autoim-
mune diseases including inflammatory bowel disease, mul-
tiple sclerosis, and Crohn’s disease were also ranked within
top ten. The relationship between TMAO and autoim-
mune diseases warrants further investigation.





Certain infectious and parasitic dis-
eases
11,598 Diseases of the circulatory system 5544
Neoplasms 14,158 Diseases of the respiratory system 3156
Diseases of the blood and blood forming organs and certain
disorders
involving the immune mechanism
3264 Diseases of the digestive system 5960
Endocrine, nutritional and metabolic
diseases
5438 Diseases of the skin and subcutaneous tissue 4390
Mental and behavioural disorders 6162 Diseases of the musculoskeletal system and connective tissue 11520
Diseases of the nervous system 5258 Diseases of the genitourinary system 5247
Diseases of the eye and adnexa 3735 Congenital malformations, deformations and chromosomal
abnormalities
9064
Diseases of the ear and mastoid process 1815 Certain conditions originating in the
perinatal period
3454
Figure 2 Finding interplaying genetic ways for TMAO and CRC. Finding putative genetic pathways linking TMAO to CRC.
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Strikingly, among top ten TMAO-related diseases
retrieved from EIN_OMIM, seven are cancers, including
CRC, breast cancer, gastric cancer and leukemia. Because
of the strong (causal) disease-gene associations in the large
OMIM database, the observed strong relationship between
TMAO and cancers implies that TMAO might be geneti-
cally involved in not only CRC but also cancers in general,
which we further confirmed in the next section.
Cancers and metabolic syndromes are highly related to
TMAO in general
We examined the distributions of sixteen disease classes
among 4,732 TMAO-related diseases retrieved from
EIN_OMIM at 10 different ranking cutoffs (top 10%,
20%, . . . 100%). Among the sixteen disease classes, only
two disease classes were enriched among top-ranked
TMAO-related diseases: Neoplasms and Endocrine, nutri-
tional and metabolic diseases (Figure 3). For example,
11.79% of the top 10% ranked diseases were neoplasms,
representing a significant 211.9% increase as compared to
3.79% of neoplasms among all retrieved diseases.
Similarly, a total of 18.74% of the top 10% ranked dis-
eases were metabolic diseases, representing a 47.8%
increase as compared to 12.68% among all retrieved dis-
eases. Given the limited number of diseases contained in
the GWAS catalog, we did not perform disease enrich-
ment analysis on diseases/traits retrieved from
EIN_GWAS.
Putative genetic pathways linking CRC to TMAO
We demonstrated that CRC was highly related to TMAO
in afore-mentioned sections. We next investigated com-
mon genetic pathways that are involved in both TMAO
and CRC. The 54 TMAO-associated human genes are
involved in a total of 170 pathways. The 53 CRC genes
based on OMIM genetics are involved in 503 pathways
and the 65 CRC genes based on GWAS studies are asso-
ciated with 182 pathways. Although no specific genes are
shared between TMAO and CRC, many common genetic
pathways are associated with both: 52 common pathways
between TMAO and CRC based on OMIM genes and 39
common pathways based on GWAS genetics (Table 5).
Even though there is no overlap between the 53 CRC-
associated genes identified from OMIM and the 65 CRC-
associated genes identified from the GWAS catalog, these
genes shared 118 pathways, which we used to identify
genetic pathways linking CRC and TMAO. We found that
TMAO shared 20 pathways of these 118 CRCrelated path-
ways with CRC. The top 10 ranked common pathways
between TMAO and CRC (OMIM), TMAO and CRC
(GWAS), and TMAO and CRC-genes from both OMIM
and GWAS are shown in Table 6.
Discussion
Recent studies have shown a mechanistic link between
TMAO, gut microbial metabolism of dietary meat and fat,
and risk of cardiovascular diseases (CVDs), and established
an obligatory role of gut microbiota in the generation of
the proatherosclerotic TMAO from dietary L-carnitine
Table 3. Top 10 ranked cardiovascular diseases and its related risk factors





Obesity-related traits 0.11% Myocardial infarction, susceptibility to 0.23%
Coronary heart disease 0.80% Ventricular tachycardia 0.25%
HDL cholesterol 1.13% Diabetes mellitus, noninsulin-dependent 0.32%
Type 2 diabetes 1.48% Coronary artery disease, susceptibility to 0.51%
LDL cholesterol 1.82% LDL cholesterol level qt 0.66%
Total cholesterol 1.94% Hypercholesterolemia, familial 0.68%
Triglycerides 3.30% Microvascular complications of diabetes 0.69%
Lipid metabolism phenotypes 3.53% Atherosclerosis, susceptibility to 0.78%
Metabolic syndrome 3.64% Obesity, susceptibility to 1.88%
Cardiovascular disease risk factors 4.55% Diabetes mellitus, type 2, susceptibility
to
3.14%
Table 4. Top ten TMAO-related diseases/traits retrieved




1 Obesity-related traits Colorectal cancer, somatic
2 Height Breast cancer, somatic
3 Igg glycosylation Gastric cancer, somatic
4 Metabolite levels Ovarian cancer, somatic
5 Inflammatory bowel disease Schizophrenia, susceptibility to
6 Multiple sclerosis Asthma, susceptibility to
7 Coronary heart disease Leukemia, acute myeloid
8 Crohn’s disease Bladder cancer, somatic
9 Metabolic traits Malaria, cerebral, susceptibility to
10 HDL cholesterol Thyroid carcinoma, follicular,
somatic
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and phosphatidylcholine, abundant in red meat and diet-
ary fat respectively [11-14]. Employing a genome-wide sys-
tems analysis approach, we confirmed the association of
TMAO with CVDs and other related metabolic disorders
such as dyslipidemia. Indeed, inhibition of reverse choles-
terol transport has been identified as an important
mechanism by which TMAO promotes atherosclerosis
[11,13]. Although in vitro and in vivo study data linking
TMAO to CRC is still lacking, our present study revealed
a striking strong association between TMAO and CRC,
and TMAO appears to be involved in many genetic path-
ways clearly implicated in cancer in general and colon car-
cinogenesis in particular.
High red meat and animal fat intakes have been well
established as risk factors for both CVDs and colorectal
cancer. The discovery of the TMAO-CVDs connection
mediated by gut microbial metabolism provides evidence
for a novel mechanism by which human gut microbiota
may influence health and disease. Gut microbiota has
long been postulated to modulate risk of CRC. Although
increasing evidence shows gut microbial community dif-
ferences in patients with and without colorectal neoplasia
[8-10], the exact mechanisms by which gut microbiota
may affect colon carcinogenesis is unknown. Our current
study, motivated by the similarity of CVDs and CRC in
risk association with dietary red meat and fat consump-
tion suggests that TMAO may also be an important and
unappreciated intermediate linking red meat and fat
intakes and gut microbiota metabolism to the develop-
ment of CRC. In vitro and in vivo data directly linking
TMAO, gut microbial metabolism of meat and fat to
CRC is still lacking. Results from our present study thus
shall be only considered as hypothesis generating and
warrant further investigations.
Conclusions
In this study, we present an unbiased data-driven network-
based approach to uncover genetic links between TMAO
and CRC by integrating and reasoning over vast amounts
of disease genetics, protein interactions, and interactions
of chemicals and proteins. Our approach is generic and
can be readily retargeted to discover novel genetic links
among any diseases and chemicals. Our genome-wide ana-
lysis demonstrates that systems approaches hold promise
for the discovery of novel disease genetic basis. Our results
show that TMAO is genetically associated with CRC. This
Figure 3 Disease enrichment analysis for TMAO-related diseases at 10 different ranking cutoffs. Enrichment of disease classes among
TMAO-related diseases at ten ranking cutoffs. TMAO-related diseases were retrieved from the OMIM-based network. The other nine disease
classes (not shown) were not enriched among top-ranked diseases.
Table 5. Numbers of shared genes and pathways
between TMAO and CRC
Genes (n) Pathways (n)
TMAO 54 170
CRC (OMIM) 53 503
CRC (GWAS) 65 182
CRC (OMIM) ∩ CRC (GWAS) 0 118
TMAO ∩ CRC (OMIM) 0 52
TMAO ∩ CRC (GWAS) 0 39
TMAO ∩ CRC (OMIM) ∩ CRC (GWAS) 0 20
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study suggests that TMAO may be an important inter-
mediate marker linking dietary meat and fat and gut
microbiota metabolism to risk of CRC, underscoring
opportunities for the development of new gut micro-
biome-dependent diagnostic tests and therapeutics
for CRC.
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